| Dr Michael Joseph Gaffud, MD | |
|
1020 E Ogden Ave Ste 301, Naperville, IL 60563-8611 | |
| (630) 545-7565 | |
| Not Available |
| Full Name | Dr Michael Joseph Gaffud |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 22 Years |
| Location | 1020 E Ogden Ave Ste 301, Naperville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124289137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 036116644 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
People who are seeking treatment for alcohol dependence and whose goal is to quit drinking entirely are more likely to achieve this goal if they are treated by a care provider who advocates total abstinence.
A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
People who are seeking treatment for alcohol dependence and whose goal is to quit drinking entirely are more likely to achieve this goal if they are treated by a care provider who advocates total abstinence.
A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Joseph Gaffud, MD 1860 Paysphere Cir, Chicago, IL 60674-0001 Ph: () - | Dr Michael Joseph Gaffud, MD 1020 E Ogden Ave Ste 301, Naperville, IL 60563-8611 Ph: (630) 545-7565 |
News Archive
Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.
Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.
People who are seeking treatment for alcohol dependence and whose goal is to quit drinking entirely are more likely to achieve this goal if they are treated by a care provider who advocates total abstinence.
A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
› Verified 2 days ago
James W Wielgolewski, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 120 Spalding Dr, Suite 100, Naperville, IL 60540 Phone: 630-961-0423 Fax: 630-961-9280 | |
Ahmad Nourallah, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1948 Three Farms Ave, Naperville, IL 60540 Phone: 630-355-5633 Fax: 630-355-5215 | |
Louis C Montana, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Spalding Dr, Ste 100, Naperville, IL 60540 Phone: 630-961-0423 Fax: 630-961-9280 | |
Morta Lapkus, Surgery Medicare: Medicare Enrolled Practice Location: 120 Spalding Dr Ste 205, Naperville, IL 60540 Phone: 630-646-6020 Fax: 630-527-3400 | |
Dr. Robert R Payton, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 W Martin Ave Ste 225, Naperville, IL 60540 Phone: 630-355-5633 | |
Dr. George I. Salti, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Spalding Dr Ste 205, Naperville, IL 60540 Phone: 630-646-6020 Fax: 630-527-3400 |